<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.0 20120330//EN" "http://jats.nlm.nih.gov/publishing/1.0/JATS-journalpublishing1.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="article-commentary" dtd-version="1.0" xml:lang="en">
<front>
<journal-meta>
<journal-id journal-id-type="issn">1043-3155</journal-id>
<journal-id journal-id-type="nlm-ta">Pediatr Neurol Briefs</journal-id>
<journal-id journal-id-type="pmc">pedneurbriefs</journal-id>
<journal-id journal-id-type="iso-abbrev">Pediatr Neurol Briefs</journal-id>
<journal-title-group>
<journal-title>Pediatric Neurology Briefs</journal-title>
<abbrev-journal-title>Pediatr Neurol Briefs</abbrev-journal-title>
</journal-title-group>
<issn pub-type="epub">2166-6482</issn>
<issn pub-type="ppub">1043-3155</issn>
<issn-l>2166-3155</issn-l>
<publisher>
<publisher-name>Pediatric Neurology Briefs Publishers</publisher-name>
<publisher-loc>Chicago, IL, USA</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">PNB-14-28-b</article-id>
<article-id pub-id-type="doi">10.15844/pedneurbriefs-14-4-7</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Seizure Disorders</subject>
</subj-group>
<subj-group subj-group-type="Discipline-v2">
<subject>Neurology</subject>
<subject>Pediatrics</subject>
<subject>Nervous System Diseases</subject>
<subject>Child Development</subject>
<subject>Brain Diseases</subject>
<subject>Neurosurgery</subject>
<subject>Child</subject>
<subject>Infant</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>High-Dose IV Steroids in Landau-Kleffner Syndrome</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-0173-7931</contrib-id>
<name>
<surname>Millichap</surname>
<given-names>J. Gordon</given-names>
</name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="AF0001">1</xref>
<xref ref-type="aff" rid="AF0002">2</xref>
<xref ref-type="corresp" rid="cor1">&#x002A;</xref>
</contrib>
</contrib-group>
<aff id="AF0001">
<label>1</label>Division of Neurology, Children&#x0027;s Memorial Hospital, Chicago, IL</aff>
<aff id="AF0002">
<label>2</label>Departments of Pediatrics and Neurology, Northwestern University Feinberg School of Medicine, Chicago, IL</aff>
<author-notes>
<corresp id="cor1"><label>&#x002A;</label>Correspondence: Dr. J. Gordon Millichap, E-mail: <email xlink:href="jgmillichap@northwestern.edu">jgmillichap@northwestern.edu</email>
</corresp>
</author-notes>
<pub-date date-type="pub" publication-format="print">
<month>04</month>
<year>2000</year>
</pub-date>
<pub-date date-type="pub" publication-format="electronic">
<day>01</day>
<month>04</month>
<year>2016</year>
</pub-date>
<volume>14</volume>
<issue>4</issue>
<fpage>28</fpage>
<lpage>29</lpage>
<permissions>
<copyright-statement>Copyright: &#x00A9; 2000 The Author(s)</copyright-statement>
<copyright-year>2000</copyright-year>
<license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0/">
<license-p>This work is licensed under the <uri xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution 4.0 International License</uri>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
</license>
</permissions>
<related-article id="R1" related-article-type="commentary-article" ext-link-type="doi" xlink:href="10.1016/S0887-8994(99)00127-7" vol="22" page="145">
<article-title>Effects of high-dose intravenous corticosteroid therapy in Landau-Kleffner syndrome</article-title>
</related-article>
<abstract abstract-type="web-summary" specific-use="electronic-only">
<p>Intravenous therapy with methylpredisolone (20 mg/kg daily) was effective in two six-year-old children with Landau-Kleffner syndrome treated at Jichi Medical School, Tochigi, Japan.</p>
</abstract>
<kwd-group>
<kwd>High-Dose IV Corticosteroids</kwd>
<kwd>Landau-Kleffner Syndrome</kwd>
<kwd>Benzodiazepine</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<p>Intravenous therapy with methylpredisolone (20 mg/kg daily) was effective in two six-year-old children with Landau-Kleffner syndrome treated at Jichi Medical School, Tochigi, Japan. A combination of valproate and a benzodiazepine had previously resulted in decreased seizures and EEG improvement, but speech and language were not improved. After 3 consecutive daily treatments with high-dose IV corticosteroids, speech was increased and receptive language improved. After a third course of therapy, the children could speak in sentences, and their subsequent language development was sustained. [<xref ref-type="bibr" rid="CIT0001">1</xref>]</p>
<p>COMMENT. High-dose corticosteroid therapy, administered early at the first appearance of symptoms, has been recommended in previous reports (<underline>Progress in Pediatric Neurology II</underline>, PNB Publ, 1994;pp221-226). [<xref ref-type="bibr" rid="CIT0002">2</xref>, <xref ref-type="bibr" rid="CIT0003">3</xref>]</p>
</body>
<back>
<ref-list>
<ref id="CIT0001">
<label>1</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tsuru</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Mori</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Mizuguchi</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Momoi</surname>
<given-names>MY</given-names>
</name>
</person-group>
<article-title>Effects of high-dose intravenous corticosteroid therapy in Landau-Kleffner syndrome</article-title>
<source>Pediatr Neurol</source>
<year>2000</year>
<month>Feb</month>
<volume>22</volume>
<issue>2</issue>
<fpage>145</fpage>
<lpage>147</lpage>
<pub-id pub-id-type="doi">10.1016/S0887-8994(99)00127-7</pub-id>
<pub-id pub-id-type="pmid">10738922</pub-id>
</element-citation>
</ref>
<ref id="CIT0002">
<label>2</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Marescaux</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Hirsch</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Finck</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Maquet</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Schlumberger</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Sellal</surname>
<given-names>F</given-names>
</name>
<etal/>
</person-group>
<article-title>Landau-Kleffner syndrome: a pharmacologic study of five cases</article-title>
<source>Epilepsia</source>
<year>1990</year>
<month>Nov-Dec</month>
<volume>31</volume>
<issue>6</issue>
<fpage>768</fpage>
<lpage>777</lpage>
<pub-id pub-id-type="doi">10.1111/j.1528-1157.1990.tb05518.x</pub-id>
<pub-id pub-id-type="pmid">1700953</pub-id>
</element-citation>
</ref>
<ref id="CIT0003">
<label>3</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lerman</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Lerman-Sagie</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Kivity</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>Effect of early corticosteroid therapy for Landau-Kleffner syndrome</article-title>
<source>Dev Med Child Neurol</source>
<year>1991</year>
<month>Mar</month>
<volume>33</volume>
<issue>3</issue>
<fpage>257</fpage>
<lpage>260</lpage>
<pub-id pub-id-type="doi">10.1111/j.1469-8749.1991.tb05115.x</pub-id>
<pub-id pub-id-type="pmid">1709123</pub-id>
</element-citation>
</ref>
</ref-list>
</back>
</article>